Skip to main content

Site Navigation

Site Search

Background

Building Breakthroughs in Biotech

Client is a cutting-edge biotech company specializing in advanced biomaterials. Like many early-stage companies focused on innovation, the company was heads down building breakthrough technology — without realizing they were potentially leaving significant tax benefits on the table. At the time, they were working with a small accounting firm that lacked specialized R&D expertise. The team didn’t believe they qualified for research credits, especially given they were generating Net Operating Losses (NOLs) and consequently no income tax liability.

The Challenge

Specialized Support at a Pivotal Time

As the company moved through a critical growth phase, they faced a number of tax-related challenges:

  • Limited R&D insight: Their accounting firm didn’t have an R&D tax credit specialist and had never advised them on eligibility.
  • Missed opportunities: Despite consistent research activity, the company had never claimed the R&D payroll tax credit and was unaware that NOL-generating companies could still benefit from it.
  • Time-sensitive eligibility: 2024 was the final year they would be eligible for the payroll offset based on IRS requirements.
How KLR Responded

Acting Fast to Maximize Benefits

KLR’s R&D Tax Credit team quickly assessed the company’s activities and identified QREs that had previously gone unclaimed. Working collaboratively with the internal team, KLR:

  • Amended the 2023 return to carry forward R&D credits that had been overlooked.
  • Prepared the 2024 return concurrently to capture the payroll offset and streamline reporting.
  • Ensured compliance and timing so the company could take advantage of the payroll tax credit before the eligibility window closed.

By managing both years at once, KLR made the process efficient, reduced the administrative burden, and ensured nothing slipped through the cracks.

Key Outcomes

Turning Missed Credits into Real Savings

Payroll Tax Savings: The company secured a $20,000 payroll tax credit by capitalizing on its final year of eligibility for the R&D payroll tax offset.

Federal Tax Benefit: Over $400,000 in previously unclaimed qualified research expenses (QREs) were identified and documented.

Audit Protection: KLR amended past returns without triggering audit risk, ensuring compliance and accuracy.

Strategic Tax Planning: The company laid the foundation for future tax strategy conversations as it scales and continues innovating.

Let's Connect

Missing out on valuable R&D credits?

Our specialists help businesses uncover and claim what they’ve earned—because when it comes to complex tax strategy, experience matters.

Deborah Pallasch, Partner, Tax Services Group

View bio
up arrow Scroll to Top